The incorporation of MALDI mass spectrometry imaging in studies to identify markers of toxicity following in utero opioid exposures in mouse fetuses
IntroductionIn 2015, the FDA released a Drug Safety Communication regarding a possible link between opioid exposure during early pregnancy and an increased risk of fetal neural tube defects (NTDs). At the time, the indications for opioid use during pregnancy were not changed due to incomplete matern...
Saved in:
| Main Authors: | Dustyn Barnette, Amy L. Inselman, Pravin Kaldhone, Grace S. Lee, Kelly Davis, Sumit Sarkar, Pritpal Malhi, J. Edward Fisher, Joseph P. Hanig, Richard D. Beger, E. Ellen Jones |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Toxicology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/ftox.2024.1452974/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delineating lipidomic landscapes in human and mouse ovaries: Spatial signatures and chemically-induced alterations via MALDI mass spectrometry imaging
by: Natalia Pascuali, et al.
Published: (2024-12-01) -
Opioid analgesics: Managing the predictable
by: A Barnes, et al.
Published: (2025-07-01) -
Cross-National Analysis of Opioid Prescribing Patterns: Enhancements and Insights from the OralOpioids R Package in Canada and the United States
by: Ankona Banerjee, et al.
Published: (2024-09-01) -
Sex-Specific Concordance of Striatal Transcriptional Signatures of Opioid Addiction in Human and Rodent Brains
by: Micah A. Shelton, et al.
Published: (2025-05-01) -
PHARMACOEPIDEMIOLOGICAL PARAMETERS OF USE OF POTENT OPIOIDS IN SAINT PETERSBURG (in the light of differences in approaches to using the drugs of this group in Russia and in the world)
by: M. V. Pchelintsev, et al.
Published: (2009-12-01)